Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer

The heterogeneity of an individual patient’s tumor has been linked to treatment resistance, but quantitative biomarkers to rapidly and reproducibly evaluate heterogeneity in a clinical setting are currently lacking. Using established tools available in a CAP-accredited and CLIA-certified clinical la...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Scher, Howard I., Graf, Ryon P., Schreiber, Nicole A., McLaughlin, Brigit, Jendrisak, Adam, Wang, Yipeng, Lee, Jerry, Greene, Stephanie, Krupa, Rachel, Lu, David, Bamford, Pascal, Louw, Jessica E., Dugan, Lyndsey, Vargas, Hebert A., Fleisher, Martin, Landers, Mark, Heller, Glenn, Dittamore, Ryan
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5666339/
https://ncbi.nlm.nih.gov/pubmed/28819021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-17-1353
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados